Movatterモバイル変換


[0]ホーム

URL:


CN201230913Y - Human nerve conduit with amplified self-functionality - Google Patents

Human nerve conduit with amplified self-functionality
Download PDF

Info

Publication number
CN201230913Y
CN201230913YCNU2007200947280UCN200720094728UCN201230913YCN 201230913 YCN201230913 YCN 201230913YCN U2007200947280 UCNU2007200947280 UCN U2007200947280UCN 200720094728 UCN200720094728 UCN 200720094728UCN 201230913 YCN201230913 YCN 201230913Y
Authority
CN
China
Prior art keywords
inner sleeve
nerve
artificial
sleeve support
artificial nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNU2007200947280U
Other languages
Chinese (zh)
Inventor
崔树森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to CNU2007200947280UpriorityCriticalpatent/CN201230913Y/en
Application grantedgrantedCritical
Publication of CN201230913YpublicationCriticalpatent/CN201230913Y/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Landscapes

Abstract

The utility model discloses a self functional magnifying artificial nerve canula used for surgical operation in the medical science field, and aims to provide an artificial nerve canula which can meet the requirement of defect operation restoration for long section of nerve, crassitude nerve and multiple parts of peripheral nerves and can continuously position nerve segments at intervals to promote the nerve growth. The artificial nerve canula comprises an outer sleeve and an inner sleeve which are both made of biological degradable materials, wherein the outer sleeve and the inner sleeved are sleeved together coaxially; the inner sleeve can extend out or retract along the axes of the outer sleeve; a plurality of sets of inner sleeve brackets are positioned in the inner sleeve, and each set of inner sleeve brackets is a containing cavity formed by two single inner sleeve brackets; the distance between the two single inner sleeve brackets in the containing cavity is 0.3 cm to 0.5 cm, and the distance between two adjacent containing cavities is 0.5 cm; the outer sleeve and the inner sleeve are thin-wall tube bodies with elliptical ring shaped cross section in the appearance shape; and the plurality of sets of inner sleeve brackets in the inner sleeve are fixedly connected by three artificial matrix bridges.

Description

Artificial nerve catheter from the functional amplification of body
Technical field
This utility model relates to the artificial neuron product of medical domain surgical operation clinical practice, relates to a kind of artificial nerve catheter from the functional amplification of body or rather.
Background technology
Long section, reparation thick and the many places peripheral nerve defection are the still unsolved so far difficult problems of surgical field.Nerve autograft is repaired neurologic defect, be acknowledged as ideal method, but owing to can only repair the major function nerve with the tegumentary nerve of very thin secondary function, not only repairing effect is not good enough, and owing to the nerve disappearance for the district causes new dysfunction occurring for the district, so the autologous nerve source is greatly limited.
Allosome and xenogenesis neural transplantation because xenogenesis neural transplantation rejection is still unresolved, only limit to the animal experiment study stage.
Therefore, people begin the human nerve that the using artificial neural conduit comes repair deficiency.According to the difference of material therefor, artificial nerve catheter can be divided into three major types:
1. the biotype material mainly comprises vein, tremulous pulse, skeletal muscle, cord vessels etc.;
2. abiotic degradable synthetic material mainly contains silica gel tube;
3. the biodegradable synthetic material mainly comprises chitin, chitosan, polylactic acid etc.
Whether in addition, can be absorbed by human body according to artificial nerve catheter, the used material of artificial nerve catheter can be divided into absorbable material and absorbable material not; According to the situation of artificial nerve catheter to surrounding material permeability, the used material of artificial nerve catheter can be divided into half permeable materials and non-permeable materials etc.
Single artificial nerve catheter has certain effect in the reparation of short distance (less than 3 centimetres) neurologic defect, but lack active single non-nervous tissue can't repair in, a long section neurologic defect.
Promote nerve growth though there is the people in artificial nerve catheter, to place a neural segment abroad in the document, be only limited to short distance (less than 3 centimetres) neurologic defect situation.Continuously, the neural segment of spaced placement promote in, long section (greater than 10 a centimetres) nerve growth, yet there are no the pertinent literature report.
Summary of the invention
The technical problem that this utility model solves provides a kind of artificial nerve catheter, a kind of long section, thick and the requirement of many places peripheral nerve defection surgical repair that is specially adapted to especially is provided, and the neural segment of continuous, spaced placement promotes the artificial nerve catheter from the functional amplification of body of nerve growth.
Consult Fig. 1, for addressing the above problem, this utility model adopts following scheme to be achieved.Described artificial nerve catheter from the functional amplification of body is made up of trocar sheath and inner sleeve, array inner sleeve support and three artificial substratum bridges of adopting Biodegradable material to make; Trocar sheath is sleeved on the inner sleeve coaxial line, inner sleeve can stretch out in trocar sheath or indentation along coaxial line, in inner sleeve, be placed with array inner sleeve support along axis, every group of inner sleeve support is made up of two independent inner sleeve supports, formed space is called the storage chamber between two independent inner sleeve supports, the distance L between two single inner sleeve supports of storage intracavity1Be 0.3 centimetre to 0.5 centimetre, the distance L between the adjacent two storage chambeies2It is 0.5 centimetre.Array inner sleeve support is fixedly connected with three artificial substratum bridges that are parallel to the inner sleeve axis.
The width of the single inner sleeve support described in the technical scheme is 0.3 centimetre to 0.5 centimetre, the profile of single inner sleeve support is oval, the ellipsoid of inner sleeve support is processed into netted, and angle is 90 ° to 140 ° between horizontal netting twine parallel to each other and the vertical netting twine parallel to each other; The described array inner sleeve support that in inner sleeve, is placed with, be meant and determine in inner sleeve, to be placed with that to be one group at least be at most ten groups inner sleeve support according to the human nerve damage length, determine promptly in inner sleeve, to be built with that to be one at least be at most ten storage chamber; The face shaping of the trocar sheath of described artificial nerve catheter from the functional amplification of body is that cross section is the thin-walled body of oval ring, and inner sleeve is that cross section is that the thin-walled body and the centre of oval ring is that cross section is that the face shaping that the annular half thin-walled body of semiellipse is formed is the thin-walled body of U font by two ends; Described three artificial substratum bridges are to be two of centrosymmetry fixed and arranged along the long axis direction of inner sleeve support ellipsoid with the intersection point of major axis and minor axis on array inner sleeve support, and fixed and arranged is one on the intersection point of major axis and minor axis.
The beneficial effects of the utility model are:
1. the autologous nerve of using small size amplifies autologous nerve by the pipe support structure of new bio degradation material from function, for solve limited this difficult problem in autologous nerve source provide newly by way of.
2. the application of new bio degradation material pipe support structure has overcome abiotic degradable pipe and long term the chronic embedding of nerve has been pressed.
3. simple to operate, only need cut far-end in the operation between the default inner sleeve support in the artificial nerve catheter of the functional amplification of body that the new bio degradation material that the neural fragment and the fixed point of the very thin secondary function of body is positioned over it different size is made.
4. the degradable biological synthetic material of this utility model application all is to be applied to clinical biosynthesis material, and human body is not had any untoward reaction, does not therefore need to do any toxicity and immunological experiment, but can directly apply to clinical.
5. the artificial nerve catheter from the functional amplification of body made of new bio degradation material is cheap; The autologous nerve of the secondary function that the far-end of small size is very thin draws materials conveniently, safe and practical, do not need repeatedly, the many places operation, patient is easy to accept.
Description of drawings
Below in conjunction with accompanying drawing this utility model is further described:
Fig. 1 is the assembly structure sketch map along trocar sheath axis pinch in from the inner sleeve of the artificial nerve catheter of the functional amplification of body;
Fig. 2 is the assembly structure sketch map of stretching along the trocar sheath axis from the inner sleeve of the artificial nerve catheter of the functional amplification of body;
Fig. 3 is the structural representation from the inner sleeve of the artificial nerve catheter of the functional amplification of body;
Among the figure: 1. trocar sheath, 2. inner sleeve, 3. inner sleeve support, 4. artificial substratum bridge.
The specific embodiment
Below in conjunction with accompanying drawing this utility model is described in further detail:
Consult Fig. 1 to Fig. 3, adopting the cross section that new bio degradation material pla-pcl (PCL) or polylactic acid (PLA) copolymer are processed into artificial nerve catheter is trocar sheath 1, several single inner sleeve supports 3, theartificial substratum bridge 4 andinner sleeve 2 of the thin-walled body of oval ring.Inner sleeve 2 is that cross section is that the thin-walled body of oval ring and centre are to be that the face shaping that the annular half thin-walled body of semiellipse is formed is the thin-walled body of U font along oval ring long axis direction cross section by two ends, the width of singleinner sleeve support 3 is 0.3 centimetre to 0.5 centimetre, the profile of singleinner sleeve support 3 is oval, the ellipsoid ofinner sleeve support 3 is processed into netted, and angle is 90 ° to 140 ° between horizontal netting twine parallel to each other and the vertical netting twine parallel to each other.Inner sleeve 2 can be determined with the storage chamber that makes up sufficient amount according to the thickness of the length of damaged nerve, damaged nerve with the length of trocar sheath 1 cross section oval ring major axis and minor axis with length, theinner sleeve 2 of trocar sheath 1.Inner sleeve 2 is packed within the trocar sheath 1, andinner sleeve 2 will reach two tubular axis line conllinear with the accuracy of manufacture of trocar sheath 1, andinner sleeve 2 can vertically be free to slide along axis within trocar sheath 1, andinner sleeve 2 can conveniently within the trocar sheath 1 take out and conveniently put into.Take outinner sleeve 2 for 1 li from trocar sheath, length according to the damaged nerve that will repair is placed corresponding array inner sleeve support for 2 li at inner sleeve, promptly make up the storage chamber of sufficient amount, the length in storage chamber is 0.3 centimetre to 0.5 centimetre, the distance in two storage chambeies is 0.5 centimetre, threeartificial substratum bridges 4 of reuse are fixedly connected array inner sleeve support, and it is become one.Threeartificial substratum bridges 4 are parallel to the axis ofinner sleeve 2, threeartificial substratum bridges 4 are that centrosymmetry is arranged two at the long axis direction of array inner sleeve support upper edge inner sleeve support ellipsoid with the intersection point of major axis and minor axis, and layout is one on the intersection point of major axis and minor axis; Between two inner sleeve supports 3 in storage chamber, place the autologous nerve segment that cuts, will place the pulsatinginner sleeve 2 of autologous nerve then and put into trocar sheath 1, will make the human body that good whole artificial nerve catheter is positioned over needs repairing again.Use operation method at last artificial nerve trachea is connected in the neurologic defect position.The segmental work of autologous nerve of fixed point, interruption implantation small size is implemented to finish like this.
Manufacturing from the Biodegradable material that artificial nerve catheter adopted of the functional amplification of body except pla-pcl (PCL) or polylactic acid (PLA) copolymer, also adoptable Biodegradable material also has chitin and chitosan, can satisfy clinical requirement equally.
The required clinically artificial nerve catheter from the functional amplification of body may be various, so, in order to satisfy clinical needs, can be standby according to the artificial nerve catheter that the neural thickness of the human body breakage of clinical practice, damaged neural length are processed into different model from the functional amplification of body.
Artificial nerve trachea is connected in the operational approach at neurologic defect position:
At first anesthesia back is cut skin, is appeared from disconnected, damaged peripheral nerve, with scalpel, after distal nerve is trimmed to normal nervous tissue, measure the physical length of neurologic defect, selects the artificial nerve trachea of respective length for use nearly.Earlier artificial nerve tracheainner sleeve 2 is vertically pulled out, group number according to the default support of inner sleeve, cut the branchiess normal nervous tissue segment of far-end of a plurality of suitable lengths (0.3 centimetre-0.5 centimetre), and place it in default storage intracavity, with artificial nerve trachea inner sleeve withdrawal, artificial nerve trachea trocar sheath 1 and near, distal nerve broken ends of fractured bone adventitia are carried out interrupted suture with 5/0 no wound stitching thread.
The structure of artificial nerve trachea and experimental analysis:
Along with the development of polymer material science, adopt special process catalysis to synthesize new bio degradation material pla-pcl (PCL) and polylactic acid (PLA) copolymer.Can control molecular weight of product, paradigmatic structure and degradation time by the ratio of artificial adjustment response time, monomer and catalyst.Put into practice verified, this copolymer good biocompatibility, do not find toxicity and immunological rejection and mutagenesis the reaction, the termination product be carbon dioxide and water, human body is not had any untoward reaction.Thisly possess " bite the hand which has fed one ' Biodegradable material of performance, can remove general bridge pipe from and long term the chronic embedding of nerve be pressed, can become the ideal carrier that promotes autologous nerve regeneration activity material, have special superiority to repairing neurologic defect.
By the tissue engineering means, we organically combine the carcass Schwann cell of the pipe support structure of this Biodegradable material and purification, and the tissue engineered peripheral nerve of preparation has been repaired in the rat sciatic nerve, long section is damaged more satisfactoryly.The solution of the problems such as purification, preservation and graft-rejection of human carcass Schwann cell has also obtained progress.Recently, Ikuta etc. studies confirm that: the near-end nerve of fracture is connected in the silicone tube of opening of 10mm, does not find neuranagenesis after six weeks; And the distal nerve fragment of different volumes (the long whole cross section of 5mm, the long whole cross section of 1mm, the long half section of 1mm) is implanted the open silicone tube far-end of 10mm, regenerating nerve is successfully crossed over the quality no significant difference of regenerating between silicone tube and the neural slice groups of different volumes.This result repairs neurologic defect for the development and use autologous nerve new way is provided.On the basis of these work, the pipe support structure fixed point that the finishing of this utility model success used the new bio degradation material, be interrupted the autologous nerve fragment of implanting small size, to repair long section, thick peripheral nerve defection.
Select in the human limb, the case of long section peripheral nerve defection, the neuranagenesis that can farthest promote that the animal experiment study in applying clinical early stage is determined is repaired the autologous nerve of the amplification of neurologic defect, repair patient in, long section peripheral nerve defection.Respectively by two point discrimination, electromyogram and ninhydrin test,, all obtained satisfactory result to recovering to compare Journal of Sex Research with sensation, motion and the sympathetic nerve function of postoperative before the art.

Claims (5)

1. artificial nerve catheter from the functional amplification of body, it is characterized in that described artificial nerve catheter from the functional amplification of body is made up of the trocar sheath (1) that adopts Biodegradable material to make and inner sleeve (2), array inner sleeve support and three artificial substratum bridges (4); Trocar sheath (1) being sleeved on inner sleeve (2) coaxial line, inner sleeve (2) can stretch out or indentation in trocar sheath (1) along coaxial line, be placed with array inner sleeve support in inner sleeve (2) lining along axis, every group of inner sleeve support is made up of two independent inner sleeve supports (3), formed space is called the storage chamber between two independent inner sleeve supports (3), the distance L between two independent inner sleeve supports (3) in formation storage chamber1Be 0.3 centimetre to 0.5 centimetre, the distance L between the adjacent two storage chambeies2Be 0.5 centimetre, array inner sleeve support is fixedly connected with three artificial substratum bridges (4) that are parallel to inner sleeve (2) axis.
CNU2007200947280U2007-12-062007-12-06Human nerve conduit with amplified self-functionalityExpired - LifetimeCN201230913Y (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CNU2007200947280UCN201230913Y (en)2007-12-062007-12-06Human nerve conduit with amplified self-functionality

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CNU2007200947280UCN201230913Y (en)2007-12-062007-12-06Human nerve conduit with amplified self-functionality

Publications (1)

Publication NumberPublication Date
CN201230913Ytrue CN201230913Y (en)2009-05-06

Family

ID=40617287

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CNU2007200947280UExpired - LifetimeCN201230913Y (en)2007-12-062007-12-06Human nerve conduit with amplified self-functionality

Country Status (1)

CountryLink
CN (1)CN201230913Y (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN100560037C (en)*2007-12-062009-11-18崔树森Artificial nerve catheter from the functional amplification of body
CN102573986A (en)*2009-06-092012-07-11赛博恩特医疗器械公司Nerve cuff with pocket for leadless stimulator
CN102836016A (en)*2011-06-202012-12-26中山大学附属第一医院Implantable degradable device for promoting nerve regeneration after peripheral nerve transplantation
US8788034B2 (en)2011-05-092014-07-22Setpoint Medical CorporationSingle-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8855767B2 (en)2009-12-232014-10-07Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US8996116B2 (en)2009-10-302015-03-31Setpoint Medical CorporationModulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en)2009-05-012015-12-15Setpoint Medical CorporationExtremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9211409B2 (en)2008-03-312015-12-15The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation of T-cell activity
US9572983B2 (en)2012-03-262017-02-21Setpoint Medical CorporationDevices and methods for modulation of bone erosion
US9662490B2 (en)2008-03-312017-05-30The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9833621B2 (en)2011-09-232017-12-05Setpoint Medical CorporationModulation of sirtuins by vagus nerve stimulation
US9931121B2 (en)2011-10-172018-04-03University Of Utah Research FoundationMethods and devices for connecting nerves
US10314501B2 (en)2016-01-202019-06-11Setpoint Medical CorporationImplantable microstimulators and inductive charging systems
US10583304B2 (en)2016-01-252020-03-10Setpoint Medical CorporationImplantable neurostimulator having power control and thermal regulation and methods of use
US10596367B2 (en)2016-01-132020-03-24Setpoint Medical CorporationSystems and methods for establishing a nerve block
US10695569B2 (en)2016-01-202020-06-30Setpoint Medical CorporationControl of vagal stimulation
US10842494B2 (en)2011-10-172020-11-24University Of Utah Research FoundationMethods and devices for connecting nerves
US10912712B2 (en)2004-03-252021-02-09The Feinstein Institutes For Medical ResearchTreatment of bleeding by non-invasive stimulation
US11051744B2 (en)2009-11-172021-07-06Setpoint Medical CorporationClosed-loop vagus nerve stimulation
US11173307B2 (en)2017-08-142021-11-16Setpoint Medical CorporationVagus nerve stimulation pre-screening test
US11207518B2 (en)2004-12-272021-12-28The Feinstein Institutes For Medical ResearchTreating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11260229B2 (en)2018-09-252022-03-01The Feinstein Institutes For Medical ResearchMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11311725B2 (en)2014-10-242022-04-26Setpoint Medical CorporationSystems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en)2015-02-032022-08-09Setpoint Medical CorporationApparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US11471681B2 (en)2016-01-202022-10-18Setpoint Medical CorporationBatteryless implantable microstimulators
US11938324B2 (en)2020-05-212024-03-26The Feinstein Institutes For Medical ResearchSystems and methods for vagus nerve stimulation
US12172017B2 (en)2011-05-092024-12-24Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders
US12343535B2 (en)2019-04-122025-07-01Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders

Cited By (55)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US10912712B2 (en)2004-03-252021-02-09The Feinstein Institutes For Medical ResearchTreatment of bleeding by non-invasive stimulation
US11207518B2 (en)2004-12-272021-12-28The Feinstein Institutes For Medical ResearchTreating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CN100560037C (en)*2007-12-062009-11-18崔树森Artificial nerve catheter from the functional amplification of body
US9662490B2 (en)2008-03-312017-05-30The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en)2008-03-312015-12-15The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation of T-cell activity
US9211410B2 (en)2009-05-012015-12-15Setpoint Medical CorporationExtremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9849286B2 (en)2009-05-012017-12-26Setpoint Medical CorporationExtremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US10220203B2 (en)2009-06-092019-03-05Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
US12251558B2 (en)2009-06-092025-03-18Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
CN102573986A (en)*2009-06-092012-07-11赛博恩特医疗器械公司Nerve cuff with pocket for leadless stimulator
US9174041B2 (en)2009-06-092015-11-03Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
US10716936B2 (en)2009-06-092020-07-21Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
US8886339B2 (en)2009-06-092014-11-11Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
US9700716B2 (en)2009-06-092017-07-11Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
US8996116B2 (en)2009-10-302015-03-31Setpoint Medical CorporationModulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US11051744B2 (en)2009-11-172021-07-06Setpoint Medical CorporationClosed-loop vagus nerve stimulation
US9162064B2 (en)2009-12-232015-10-20Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US9993651B2 (en)2009-12-232018-06-12Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US12290695B2 (en)2009-12-232025-05-06Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US8855767B2 (en)2009-12-232014-10-07Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US10384068B2 (en)2009-12-232019-08-20Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US11110287B2 (en)2009-12-232021-09-07Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US8788034B2 (en)2011-05-092014-07-22Setpoint Medical CorporationSingle-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US12172017B2 (en)2011-05-092024-12-24Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders
US12357826B2 (en)2011-05-092025-07-15Setpoint Medical CorporationExtremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN102836016A (en)*2011-06-202012-12-26中山大学附属第一医院Implantable degradable device for promoting nerve regeneration after peripheral nerve transplantation
US9833621B2 (en)2011-09-232017-12-05Setpoint Medical CorporationModulation of sirtuins by vagus nerve stimulation
US10772633B2 (en)2011-10-172020-09-15University Of Utah Research FoundationMethods and devices for connecting nerves
US9931121B2 (en)2011-10-172018-04-03University Of Utah Research FoundationMethods and devices for connecting nerves
US10842494B2 (en)2011-10-172020-11-24University Of Utah Research FoundationMethods and devices for connecting nerves
US9572983B2 (en)2012-03-262017-02-21Setpoint Medical CorporationDevices and methods for modulation of bone erosion
US10449358B2 (en)2012-03-262019-10-22Setpoint Medical CorporationDevices and methods for modulation of bone erosion
US12402826B2 (en)2013-04-102025-09-02Setpoint Medical CorporationClosed-loop vagus nerve stimulation
US11969253B2 (en)2013-04-102024-04-30Setpoint Medical CorporationClosed-loop vagus nerve stimulation
US12383741B2 (en)2014-10-242025-08-12Setpoint Medical CorporationSystems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11311725B2 (en)2014-10-242022-04-26Setpoint Medical CorporationSystems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en)2015-02-032022-08-09Setpoint Medical CorporationApparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US11278718B2 (en)2016-01-132022-03-22Setpoint Medical CorporationSystems and methods for establishing a nerve block
US10596367B2 (en)2016-01-132020-03-24Setpoint Medical CorporationSystems and methods for establishing a nerve block
US12296169B2 (en)2016-01-202025-05-13Setpoint Medical CorporationBatteryless implantable microstimulators
US11547852B2 (en)2016-01-202023-01-10Setpoint Medical CorporationControl of vagal stimulation
US10695569B2 (en)2016-01-202020-06-30Setpoint Medical CorporationControl of vagal stimulation
US11964150B2 (en)2016-01-202024-04-23Setpoint Medical CorporationBatteryless implantable microstimulators
US12121726B2 (en)2016-01-202024-10-22Setpoint Medical CorporationControl of vagal stimulation
US11471681B2 (en)2016-01-202022-10-18Setpoint Medical CorporationBatteryless implantable microstimulators
US10314501B2 (en)2016-01-202019-06-11Setpoint Medical CorporationImplantable microstimulators and inductive charging systems
US11383091B2 (en)2016-01-252022-07-12Setpoint Medical CorporationImplantable neurostimulator having power control and thermal regulation and methods of use
US10583304B2 (en)2016-01-252020-03-10Setpoint Medical CorporationImplantable neurostimulator having power control and thermal regulation and methods of use
US11890471B2 (en)2017-08-142024-02-06Setpoint Medical CorporationVagus nerve stimulation pre-screening test
US11173307B2 (en)2017-08-142021-11-16Setpoint Medical CorporationVagus nerve stimulation pre-screening test
US11260229B2 (en)2018-09-252022-03-01The Feinstein Institutes For Medical ResearchMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US12220579B2 (en)2018-09-252025-02-11The Feinstein Institutes For Medical ResearchMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11857788B2 (en)2018-09-252024-01-02The Feinstein Institutes For Medical ResearchMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US12343535B2 (en)2019-04-122025-07-01Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders
US11938324B2 (en)2020-05-212024-03-26The Feinstein Institutes For Medical ResearchSystems and methods for vagus nerve stimulation

Similar Documents

PublicationPublication DateTitle
CN201230913Y (en)Human nerve conduit with amplified self-functionality
CN103800097B (en)A kind of tissue repair fibrous membrane and manufacture method thereof and application
US5925053A (en)Multi-lumen polymeric guidance channel, method for promoting nerve regeneration, and method of manufacturing a multi-lumen nerve guidance channel
CN100560037C (en)Artificial nerve catheter from the functional amplification of body
EP2921136A1 (en)Fiber membranes for repairing tissue and products and preparation method thereof
CN103800096B (en)Pelvic floor dysfunction disease reparation is with implanting fiber diaphragm, preparation method and the medical apparatus and instruments containing it
CN103800942B (en)Pelvic floor patch
CN104717938B (en)filler for removing wrinkle
CN201426912Y (en)High-voltage expansive balloon structure
CN101815545A (en)Be used to promote the prosthese of reconstruction in hollow organ or the hollow organ's part body
WO2012106707A3 (en)Biosynthetic functional cellulose (bc) fibers as surgical sutures and reinforcement of implants and growing tissue
US20140107803A1 (en)Engineered tissue scaffolds and supports therefor
CN102481149A (en) Coated wire with anchoring structure for anchoring in biological tissue
CN101427947B (en)Multifunctional female pelvic cavity biological sticking patch
ATE548414T1 (en) BIOCOMPATIBLE POLYMERS WITH A THREE-DIMENSIONAL STRUCTURE AND WITH CELLS, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN MEDICINE AND SURGERY
KR102685018B1 (en)Artificial Biological Tissue For Penile Reconstruction And Fabricating Method Thereof Using 3D Printing
CN105833340A (en)Nerve conduit with function of nerve regeneration promotion
DE4426315C1 (en) Membrane for the regeneration of body tissues and use of the membrane as a wound covering and skin replacement
CN104415402A (en)Three-dimensional patch used for nerve regeneration and dura mater repairing
CN105748171B (en)Biological nerve duct
CN109876197B (en)3D printing skin and preparation method thereof
CN101966090A (en)Tissue engineered artificial optic nerve conduit and preparation method thereof
CN106913908A (en)A kind of cell growth support with structure memory characteristic
CN201551416U (en)Multifunctional female pelvic cavity patch
CN101396292B (en)One-piece urethra hanging strip

Legal Events

DateCodeTitleDescription
C14Grant of patent or utility model
GR01Patent grant
AV01Patent right actively abandoned

Effective date of abandoning:20071206

C25Abandonment of patent right or utility model to avoid double patenting

[8]ページ先頭

©2009-2025 Movatter.jp